Water Quality in MONROE, NY (10950)
EPA violation data for public water systems serving ZIP code 10950.
931
Total Violations
23
Health-Based
908
Monitoring / Reporting
898
Resolved
What does this mean?
898 of 931 violations have been resolved. 23 are health-based violations, meaning contaminant levels exceeded federal safety limits. The remaining 908 are monitoring or reporting violations (missed testing deadlines or late paperwork — not necessarily a water quality issue). Not all violations mean your water is unsafe. The EPA requires reporting even for minor administrative issues.
Violations Detail (931 total)
| Contaminant | Category | MCL Limit | Measured | Date | Status | Health Effects |
|---|---|---|---|---|---|---|
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jul 1, 2025 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jul 1, 2025 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jul 1, 2025 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 28, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 28, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 1, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 1, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 1, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 10.9 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 10.9 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 10.9 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 8, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 8, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 24, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 24, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 24, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 24, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 24, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 31, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 11, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 11, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 29, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 29, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 29, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 22, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 22, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 25, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 25, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 25, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2024 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Mar 28, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 28, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 24, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 1, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 25, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 25, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 12 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 12 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 12 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 12 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Sep 13, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 13, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 13, 2023 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Jun 21, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 21, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 7, 2023 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Aldicarb sulfone | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| 2,4,5-TP | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Cardiovascular system or reproductive problems |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Aldicarb sulfone | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Combined Uranium | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Aldicarb sulfoxide | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Carbofuran | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Aldicarb sulfone | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Aldicarb | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Total Polychlorinated Biphenyls (PCB) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Cardiovascular system or reproductive problems |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| OXAMYL | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Cardiovascular system or reproductive problems |
| Toxaphene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| Benzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Anemia; decrease in blood platelets; increased risk of cancer |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,1-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Vinyl chloride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Increased risk of cancer |
| Vinyl chloride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| Carbon tetrachloride | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,2,4-Trichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,2-Dichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,1,1-Trichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| 1,1,2-Trichloroethane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| CHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| DICHLOROMETHANE | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| cis-1,2-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| p-Dichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Tetrachloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| trans-1,2-Dichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| o-Dichlorobenzene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Trichloroethylene | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Liver problems; increased risk of cancer |
| 1,2-Dichloropropane | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
Lead & Copper Levels
Violation Timeline
2025(36)
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
LEAD AND COPPER RULE REVISIONS
4H
LEAD AND COPPER RULE REVISIONS
4H
LEAD AND COPPER RULE REVISIONS
4H
Lead and Copper Rule
52
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
Public Notice
75
Public Notice
75
Public Notice
75
2024(86)
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
02
Arsenic
02
Arsenic
02
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
Benzene
03
Benzene
03
Revised Total Coliform Rule
4B
Revised Total Coliform Rule
4B
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
1A
Revised Total Coliform Rule
1A
Revised Total Coliform Rule
1A
Public Notice
76
Public Notice
76
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Public Notice
76
Public Notice
76
Public Notice
76
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Arsenic
03
Arsenic
03
Public Notice
76
Public Notice
76
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
2023(99)
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Benzene
03
Benzene
03
Benzene
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2022(556)
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Nitrate
03
Nitrate
03
Nitrate
03
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Groundwater Rule
41
Groundwater Rule
41
Groundwater Rule
41
Groundwater Rule
41
Groundwater Rule
41
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Aldicarb sulfone
03
Di(2-ethylhexyl) adipate
03
Picloram
03
Picloram
03
Picloram
03
Picloram
03
Toxaphene
03
Toxaphene
03
Toxaphene
03
Toxaphene
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Endrin
03
Endrin
03
Endrin
03
Endrin
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
Carbofuran
03
Carbofuran
03
Carbofuran
03
Carbofuran
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Aldicarb sulfone
03
Dalapon
03
Dalapon
03
Dalapon
03
Dalapon
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
2,4,5-TP
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Methoxychlor
03
Methoxychlor
03
Methoxychlor
03
Methoxychlor
03
2,4-D
03
2,4-D
03
2,4-D
03
2,4-D
03
Atrazine
03
Atrazine
03
Atrazine
03
Atrazine
03
Aldicarb sulfone
03
Aldicarb sulfone
03
BHC-GAMMA
03
BHC-GAMMA
03
BHC-GAMMA
03
BHC-GAMMA
03
OXAMYL
03
OXAMYL
03
OXAMYL
03
OXAMYL
03
Simazine
03
Simazine
03
Simazine
03
Simazine
03
Dinoseb
03
Dinoseb
03
Dinoseb
03
Dinoseb
03
Aldicarb
03
Aldicarb
03
Aldicarb
03
Aldicarb
03
LASSO
03
LASSO
03
LASSO
03
LASSO
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Di(2-ethylhexyl) adipate
03
2,4,5-TP
03
2,4,5-TP
03
2,4,5-TP
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
Pentachlorophenol
03
Pentachlorophenol
03
Pentachlorophenol
03
Pentachlorophenol
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
Chlordane
03
Chlordane
03
Chlordane
03
Chlordane
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Hexachlorocyclopentadiene
03
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Benzene
03
Benzene
03
Benzene
03
Benzene
03
Benzene
03
2,4,5-TP
03
2,4,5-TP
03
2,4,5-TP
03
2,4,5-TP
03
2,4,5-TP
03
BHC-GAMMA
03
BHC-GAMMA
03
BHC-GAMMA
03
BHC-GAMMA
03
LASSO
03
LASSO
03
LASSO
03
LASSO
03
LASSO
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Aldicarb
03
Aldicarb
03
Aldicarb
03
Aldicarb
03
Aldicarb
03
Carbofuran
03
Carbofuran
03
Carbofuran
03
Carbofuran
03
Carbofuran
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Endrin
03
Endrin
03
Endrin
03
Endrin
03
Endrin
03
OXAMYL
03
OXAMYL
03
OXAMYL
03
OXAMYL
03
OXAMYL
03
Methoxychlor
03
Methoxychlor
03
Methoxychlor
03
Methoxychlor
03
Methoxychlor
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
BHC-GAMMA
03
Atrazine
03
Atrazine
03
Atrazine
03
Atrazine
03
Atrazine
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Dalapon
03
Dalapon
03
Dalapon
03
Dalapon
03
Dalapon
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Picloram
03
Picloram
03
Picloram
03
Picloram
03
Picloram
03
Dinoseb
03
Dinoseb
03
Dinoseb
03
Dinoseb
03
Dinoseb
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Heptachlor epoxide
03
2,4-D
03
2,4-D
03
2,4-D
03
2,4-D
03
2,4-D
03
Pentachlorophenol
03
Pentachlorophenol
03
Pentachlorophenol
03
Pentachlorophenol
03
Pentachlorophenol
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
Chlordane
03
Chlordane
03
Chlordane
03
Chlordane
03
Chlordane
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Simazine
03
Simazine
03
Simazine
03
Simazine
03
Simazine
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Toxaphene
03
Toxaphene
03
Toxaphene
03
Toxaphene
03
Toxaphene
03
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3B
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
Arsenic
03
Arsenic
03
Arsenic
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Groundwater Rule
41
Groundwater Rule
41
Groundwater Rule
41
Groundwater Rule
41
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Benzene
03
Benzene
03
Benzene
03
Benzene
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Atrazine
03
Atrazine
03
Atrazine
03
Atrazine
03
Atrazine
03
Benzene
03
Benzene
03
Benzene
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
Heptachlor
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Heptachlor epoxide
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Combined Radium (-226 and -228)
03
Pentachlorophenol
03
Pentachlorophenol
03
Benzene
03
Benzene
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Toxaphene
03
Dinoseb
03
Dinoseb
03
Dinoseb
03
Dinoseb
03
Dinoseb
03
Toxaphene
03
Toxaphene
03
Toxaphene
03
Toxaphene
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
Carbofuran
03
Carbofuran
03
Carbofuran
03
Carbofuran
03
Carbofuran
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
2,4-D
03
LASSO
03
LASSO
03
LASSO
03
LASSO
03
LASSO
03
2,4-D
03
2,4-D
03
2,4-D
03
2,4-D
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Combined Uranium
03
Endrin
03
Endrin
03
Endrin
03
Endrin
03
Endrin
03
BHC-GAMMA
03
BHC-GAMMA
03
BHC-GAMMA
03
BHC-GAMMA
03
BHC-GAMMA
03
Pentachlorophenol
03
Pentachlorophenol
03
Pentachlorophenol
03
Methoxychlor
03
Methoxychlor
03
Methoxychlor
03
Methoxychlor
03
Methoxychlor
03
Dalapon
03
Dalapon
03
Dalapon
03
Dalapon
03
Dalapon
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
OXAMYL
03
OXAMYL
03
OXAMYL
03
OXAMYL
03
OXAMYL
03
Simazine
03
Simazine
03
Simazine
03
Simazine
03
Simazine
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Picloram
03
Picloram
03
Picloram
03
Picloram
03
Picloram
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Aldicarb
03
Aldicarb
03
Aldicarb
03
Aldicarb
03
Aldicarb
03
2,4,5-TP
03
2,4,5-TP
03
2,4,5-TP
03
2,4,5-TP
03
2,4,5-TP
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
Total Polychlorinated Biphenyls (PCB)
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
Chlordane
03
Chlordane
03
Chlordane
03
Chlordane
03
Chlordane
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
03
2021(154)
Nitrate
03
Nitrate
03
Nitrate
03
Chlordane
03
Total Polychlorinated Biphenyls (PCB)
03
Methoxychlor
03
Aldicarb sulfoxide
03
Aldicarb sulfoxide
03
Pentachlorophenol
03
Pentachlorophenol
03
Carbofuran
03
BHC-GAMMA
03
BHC-GAMMA
03
Carbofuran
03
Chlordane
03
Endrin
03
Endrin
03
Methoxychlor
03
Toxaphene
03
Dalapon
03
Dalapon
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) adipate
03
Di(2-ethylhexyl) phthalate
03
Di(2-ethylhexyl) phthalate
03
Picloram
03
Picloram
03
Dinoseb
03
Dinoseb
03
Aldicarb sulfone
03
Aldicarb sulfone
03
Aldicarb
03
Aldicarb
03
LASSO
03
LASSO
03
Heptachlor
03
Heptachlor
03
Heptachlor epoxide
03
Heptachlor epoxide
03
2,4-D
03
2,4-D
03
2,4,5-TP
03
2,4,5-TP
03
HEXACHLOROBENZENE
03
HEXACHLOROBENZENE
03
Total Polychlorinated Biphenyls (PCB)
03
Atrazine
03
ETHYLENE DIBROMIDE
03
ETHYLENE DIBROMIDE
03
Benzo(a)pyrene
03
Benzo(a)pyrene
03
Hexachlorocyclopentadiene
03
Hexachlorocyclopentadiene
03
OXAMYL
03
OXAMYL
03
Simazine
03
Simazine
03
Atrazine
03
Toxaphene
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Consumer Confidence Rule
71
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
o-Dichlorobenzene
03
Trichloroethylene
03
1,2-Dichloropropane
03
Benzene
03
Benzene
03
1,1-Dichloroethylene
03
1,1-Dichloroethylene
03
Vinyl chloride
03
Vinyl chloride
03
Carbon tetrachloride
03
Carbon tetrachloride
03
1,2,4-Trichlorobenzene
03
1,2,4-Trichlorobenzene
03
1,2-Dichloroethane
03
1,2-Dichloroethane
03
1,1,1-Trichloroethane
03
1,1,1-Trichloroethane
03
1,1,2-Trichloroethane
03
1,1,2-Trichloroethane
03
CHLOROBENZENE
03
CHLOROBENZENE
03
Toluene
03
Toluene
03
Styrene
03
Styrene
03
trans-1,2-Dichloroethylene
03
DICHLOROMETHANE
03
DICHLOROMETHANE
03
Ethylbenzene
03
Ethylbenzene
03
Tetrachloroethylene
03
cis-1,2-Dichloroethylene
03
cis-1,2-Dichloroethylene
03
p-Dichlorobenzene
03
p-Dichlorobenzene
03
Tetrachloroethylene
03
trans-1,2-Dichloroethylene
03
o-Dichlorobenzene
03
Trichloroethylene
03
1,2-Dichloropropane
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
How Does This Compare?
MONROE (10950) has 931 recorded violations, including 23 health-based. 33 remain unresolved. Consider testing your tap water independently for added peace of mind.
Recommended Water Filters
Based on the contaminants detected in your area, these filter types may help improve your water quality.
Reverse Osmosis System
Highly effective at removing heavy metals, dissolved solids, and a wide range of contaminants. Recommended for homes with lead or arsenic concerns.
Targets:Lead, Copper, Arsenic, Mercury, Cadmium
Look for:NSF/ANSI 58 certified
UV Water Purifier
Uses ultraviolet light to neutralize bacteria, viruses, and parasites without chemicals. Ideal for homes with microbial contamination concerns.
Targets:E. coli, Coliform, Giardia, Cryptosporidium
Look for:NSF/ANSI 55 (Class A) certified
Always look for filters certified by NSF International for the specific contaminants you want to remove.